Evidence map›Paper›PMID 37070811›Full record

ArticleeLife2023

A TRAF-like E3 ubiquitin ligase TrafE coordinates ESCRT and autophagy in endolysosomal damage response and cell-autonomous immunity to

Lyudmil Raykov, Manon Mottet, Jahn Nitschke, Thierry Soldati

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. SMURF2 inhibits autophagic control ofbioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Science advances · 2025
    Article
  8. Article
  9. Review
  10. Frontiers in tuberculosis · 2025
    Review
  11. Article
  12. Frontiers in microbiology · 2025
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lyudmil RaykovDépartment de Biochimie, Faculté des Sciences, University of Geneva, Geneva, Switzerland.ORCID 0000-0001-7989-610X
Manon MottetDépartment de Biochimie, Faculté des Sciences, University of Geneva, Geneva, Switzerland.
Jahn NitschkeDépartment de Biochimie, Faculté des Sciences, University of Geneva, Geneva, Switzerland.
Thierry SoldatiDépartment de Biochimie, Faculté des Sciences, University of Geneva, Geneva, Switzerland.ORCID 0000-0002-2056-7931
University of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cells are perpetually challenged by pathogens, protein aggregates or chemicals, that induce plasma membrane or endolysosomal compartments damage. This severe stress is recognised and controlled by the endosomal sorting complex required for transport (ESCRT) and the autophagy machineries, which are recruited to damaged membranes to either repair or to remove membrane remnants. Yet, insight is limited about how damage is sensed and which effectors lead to extensive tagging of the damaged organelles with signals, such as K63-polyubiquitin, required for the recruitment of membrane repair or removal machineries. To explore the key factors responsible for detection and marking of damaged compartments, we use the professional phagocyte

Indexed as

DictyosteliumMycobacterium marinumAutophagyEndosomal Sorting Complexes Required for TransportEndosomesEndosomal Sorting Complexes Required for Transportautophagycell biologydictyosteliumESCRThost-pathogen interactioninfectioninfectious diseasemembrane damagemicrobiologyMycobacterium marinum

Identifiers

PMID37070811
PMCPMC10181826
OpenAlexW4366236669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.